F-Prime

F-Prime company information, Employees & Contact Information

Explore related pages

Related company profiles:

Our roots are in one of America’s great entrepreneurial success stories. Fidelity Investments was founded in 1946 and grew from a single mutual fund into one of the largest asset management firms in the world, with over $2 trillion in assets under management. For the last forty years, our venture capital group has had the privilege of backing other great entrepreneurs as they built ground-breaking companies in technology and life sciences, including Atari, MCI, ROLM Corp., Alibaba, Ironwood Pharmaceuticals, and Ultragenyx. Today our funds are larger and more global, but our teams are still small and local. We stay true to our entrepreneurial roots. In the US and Europe, we are F-Prime Capital investing in healthcare (formerly Fidelity Biosciences) and in technology (formerly part of Devonshire Investors). In other geographies, our sister fund is called Eight Roads (formerly Fidelity Growth Partners), with investment teams in London, Shanghai, Beijing, Hong Kong, Tokyo, and Mumbai. Together we bring a world of insight, domain expertise and relationships to support our entrepreneurs. Without the pressure of fundraising from outside investors, we focus all of our time finding and helping great entrepreneurs build important companies.

Company Details

Employees
119
Address
One Main Street, Cambridge,ma 02142,united States
Phone
617-231-2400
Email
in****@****tal.com
Industry
Venture Capital And Private Equity Principals
NAICS
Miscellaneous Intermediation
HQ
Cambridge, MA
Looking for a particular F-Prime employee's phone or email?

F-Prime Questions

News

Kanastra Raises $30 Million Series B from F-Prime to Spearhead Brazil's Private Credit Infrastructure Development - PR Newswire

Kanastra Raises $30 Million Series B from F-Prime to Spearhead Brazil's Private Credit Infrastructure Development PR Newswire

TripSuite Secures $5 Million to Revolutionize the Way Travel Agencies Operate - PR Newswire

TripSuite Secures $5 Million to Revolutionize the Way Travel Agencies Operate PR Newswire

F-Prime’s Ketan Patel on ‘reverse ageism’ in biotech and investing in a downturn - BioPharma Dive

F-Prime’s Ketan Patel on ‘reverse ageism’ in biotech and investing in a downturn BioPharma Dive

F-Prime Capital Releases its 2024 State of Fintech Report - PR Newswire

F-Prime Capital Releases its 2024 State of Fintech Report PR Newswire

F-Prime Capital Launches the F-Prime Fintech Index - PR Newswire

F-Prime Capital Launches the F-Prime Fintech Index PR Newswire

Doceree Closes $11 Million Series A Funding Round Led by Eight Roads Ventures - PR Newswire

Doceree Closes $11 Million Series A Funding Round Led by Eight Roads Ventures PR Newswire

F-Prime Capital Launches State Of Robotics Report - PR Newswire

F-Prime Capital Launches State Of Robotics Report PR Newswire

K36 Therapeutics Launches with $30 Million Series A Financing from F-Prime Capital and Atlas Venture with Eight Roads Ventures - PR Newswire

K36 Therapeutics Launches with $30 Million Series A Financing from F-Prime Capital and Atlas Venture with Eight Roads Ventures PR Newswire

ARTBIO Launches to Develop New Class of Alpha Radioligand Therapies Designed to Maximize Therapeutic Potential - PR Newswire

ARTBIO Launches to Develop New Class of Alpha Radioligand Therapies Designed to Maximize Therapeutic Potential PR Newswire

Shinobi Therapeutics Launches with Completion of $51M Series A to Advance Hypoimmune iPS-T Cell Therapy Platform - PR Newswire

Shinobi Therapeutics Launches with Completion of $51M Series A to Advance Hypoimmune iPS-T Cell Therapy Platform PR Newswire

Expressable Closes $15M Series A to Expand Industry-Leading Speech Therapy Solution - PR Newswire

Expressable Closes $15M Series A to Expand Industry-Leading Speech Therapy Solution PR Newswire

Eleos Health Raises $20M to Unlock In-Session Behavioral Health Voice Data - PR Newswire

Eleos Health Raises $20M to Unlock In-Session Behavioral Health Voice Data PR Newswire

AppliedVR Raises $36 Million Series B To Scale Comprehensive Virtual Reality Platform For Healthcare - PR Newswire

AppliedVR Raises $36 Million Series B To Scale Comprehensive Virtual Reality Platform For Healthcare PR Newswire

Toku Raises USD $7.15 Million in Seed Round to Revolutionize Subscription Payments in LatAm - PR Newswire

Toku Raises USD $7.15 Million in Seed Round to Revolutionize Subscription Payments in LatAm PR Newswire

Akrevia Therapeutics Launches with $30M Series A Financing Led by F-Prime Capital Partners and Atlas Venture - PR Newswire

Akrevia Therapeutics Launches with $30M Series A Financing Led by F-Prime Capital Partners and Atlas Venture PR Newswire

NFlection Therapeutics Launches with $20M Series A Funding to Advance Lead Program in Neurofibromatosis - PR Newswire

NFlection Therapeutics Launches with $20M Series A Funding to Advance Lead Program in Neurofibromatosis PR Newswire

Latchel Closes $16.7 Million to Enhance Resident Services and Maintenance Workflow - PR Newswire

Latchel Closes $16.7 Million to Enhance Resident Services and Maintenance Workflow PR Newswire

Aerium Therapeutics launches to develop novel therapeutics against COVID-19 and future pandemic threats - PR Newswire

Aerium Therapeutics launches to develop novel therapeutics against COVID-19 and future pandemic threats PR Newswire

AmplifyMD Raises $23 Million to Improve Patient Access to Specialty Care - PR Newswire

AmplifyMD Raises $23 Million to Improve Patient Access to Specialty Care PR Newswire

Stride Health Secures $23.5 Million in Series B Funding - PR Newswire

Stride Health Secures $23.5 Million in Series B Funding PR Newswire

Centivo, a New Type of Health Plan, Raises $34 Million in Series A Funding - PR Newswire

Centivo, a New Type of Health Plan, Raises $34 Million in Series A Funding PR Newswire

Indalo Therapeutics Appoints Seasoned Biopharmaceutical Executive Robert Jacks President & CEO - PR Newswire

Indalo Therapeutics Appoints Seasoned Biopharmaceutical Executive Robert Jacks President & CEO PR Newswire

Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseases - Business Wire

Atalanta Therapeutics Launches With $110 Million to Pioneer RNAi Therapeutics for Neurodegenerative Diseases Business Wire

SpectrumAi Announces $9 Million in Seed Funding to Innovate Autism Care - Business Wire

SpectrumAi Announces $9 Million in Seed Funding to Innovate Autism Care Business Wire

Equip Raises $17 Million to Transform Eating Disorder Treatment - Business Wire

Equip Raises $17 Million to Transform Eating Disorder Treatment Business Wire

All-in-one Recruiting Platform Ashby Launches Publicly With over 500 Customers - PR Newswire

All-in-one Recruiting Platform Ashby Launches Publicly With over 500 Customers PR Newswire

Tenpoint Therapeutics Launches with $70 Million Series A Financing to Reverse Vision Loss Through Engineered Cell-Based Therapeutics and In Vivo Reprogramming - Business Wire

Tenpoint Therapeutics Launches with $70 Million Series A Financing to Reverse Vision Loss Through Engineered Cell-Based Therapeutics and In Vivo Reprogramming Business Wire

Top F-Prime Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant